M
Mehdi Raei
Researcher at Baqiyatallah University of Medical Sciences
Publications - 36
Citations - 467
Mehdi Raei is an academic researcher from Baqiyatallah University of Medical Sciences. The author has contributed to research in topics: Cancer & Epidemiology. The author has an hindex of 7, co-authored 36 publications receiving 140 citations. Previous affiliations of Mehdi Raei include Tehran University of Medical Sciences & Qom University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
Milad Ashrafizadeh,Kiavash Hushmandi,Mehrdad Hashemi,Mohammad Esmaeil Akbari,Peter Kubatka,Mehdi Raei,Lenka Koklesova,Shahinozzaman,Reza Mohammadinejad,Masoud Najafi,Gautam Sethi,Alan Prem Kumar,Ali Zarrabi +12 more
TL;DR: This review focuses on microRNAs (miRNAs) and their regulatory effect on epithelial-to-mesenchymal transition (EMT) mechanisms that can regulate metastasis ofadder cancer cells.
Journal ArticleDOI
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh,Sepideh Mirzaei,Mohammad Hossein Gholami,Farid Hashemi,Amirhossein Zabolian,Mehdi Raei,Kiavash Hushmandi,Ali Zarrabi,Nicolas H. Voelcker,Amir Reza Aref,Michael R. Hamblin,Rajender S. Varma,Saeed Samarghandian,I.J. Arostegi,M. Alzola,Alan Prem Kumar,Vijay Kumar Thakur,Noushin Nabavi,Pooyan Makvandi,Franklin R. Tay,Gorka Orive +20 more
TL;DR: Hyaluronic acid-based advanced materials provide a platform for the co-delivery of genes and drugs along with DOX to enhance the efficacy of anti-cancer therapy and overcome chemoresistance.
Journal ArticleDOI
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh,Ali Zarrabi,Kiavash Hushmandi,Farid Hashemi,Ebrahim Rahmani Moghadam,Mehdi Raei,Mahshad Kalantari,Shima Tavakol,Reza Mohammadinejad,Masoud Najafi,Franklin R. Tay,Pooyan Makvandi,Pooyan Makvandi +12 more
TL;DR: Co-delivery of natural compounds/siRNA using nanovehicles as a potent gene-editing tool in cancer therapy can maximize the synergistic effects against tumor cells.
Journal ArticleDOI
The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators.
Sepideh Mirzaei,Ali Zarrabi,Sholeh Etehad Asnaf,Farid Hashemi,Amirhossein Zabolian,Kiavash Hushmandi,Mehdi Raei,Mohammad Ali Sheikh Beig Goharrizi,Pooyan Makvandi,Saeed Samarghandian,Masoud Najafi,Milad Ashrafizadeh,Amir Reza Aref,Michael R. Hamblin +13 more
TL;DR: In this paper, the regulatory impact of miRNA-338-3p on cancer growth and migration is discussed and it seems that miRNA has dual role in cancer chemotherapy, acting as tumor-promoting or tumor-suppressor factor.
Journal ArticleDOI
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects.
Milad Ashrafizadeh,Sepideh Mirzaei,Kiavash Hushmandi,Vahid Rahmanian,Amirhossein Zabolian,Mehdi Raei,Mahdi Vasheghani Farahani,Mohammad Ali Sheikh Beig Goharrizi,Haroon Khan,Ali Zarrabi,Saeed Samarghandian +10 more
TL;DR: In this article, the authors considered a wide variety of risk factors for lung cancer development such as smoking, air pollution and family history, and found that genetic and epigenetic factors are also potential players in lung cancer progression.